Novo Nordisk AS
Kurs
Diff. Vortag in %
52 Wochen Tief
52 Wochen Hoch
- Eher Negativ
- Seit dem 17.10.2025
- Informationen von thescreener.com
Tools
Fundamentalanalyse
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 08.12.2025 12 Monate | 08.12.2025 | 12 Monate | 303,55 350 | 303,55 | 350 | 15,340254 | JPMORGAN | ||
| Novo Nordisk AS | 04.12.2025 0 Monate | 04.12.2025 | 0 Monate | 303,55 400 | 303,55 | 400 | 31,817433 | BERENBERG | ||
| Novo Nordisk AS | 03.12.2025 0 Monate | 03.12.2025 | 0 Monate | 303,55 295 | 303,55 | 295 | 2,784643 | UBS | ||
| Novo Nordisk AS | 30.11.2025 0 Monate | 30.11.2025 | 0 Monate | 303,55 270 | 303,55 | 270 | 11,023233 | JEFFERIES | ||
| Novo Nordisk AS | 28.11.2025 12 Monate | 28.11.2025 | 12 Monate | 303,55 375 | 303,55 | 375 | 23,578843 | BARCLAYS | ||
| Novo Nordisk AS | 28.11.2025 0 Monate | 28.11.2025 | 0 Monate | 303,55 315 | 303,55 | 315 | 3,806228 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 303,55 475 | 303,55 | 475 | 56,533202 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 26.11.2025 12 Monate | 26.11.2025 | 12 Monate | 303,55 353 | 303,55 | 353 | 16,328884 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 303,55 475 | 303,55 | 475 | 56,533202 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 25.11.2025 0 Monate | 25.11.2025 | 0 Monate | 303,55 500 | 303,55 | 500 | 64,771791 | JPMORGAN | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 303,55 500 | 303,55 | 500 | 64,771791 | JPMORGAN | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 303,55 290 | 303,55 | 290 | 4,432361 | JEFFERIES |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 303,55 375 | 303,55 | 375 | 23,578843 | BARCLAYS | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 303,55 391 | 303,55 | 391 | 28,851541 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 24.11.2025 0 Monate | 24.11.2025 | 0 Monate | 303,55 | 303,55 | -- | DZ BANK | |||
| Novo Nordisk AS | 17.11.2025 0 Monate | 17.11.2025 | 0 Monate | 303,55 315 | 303,55 | 315 | 3,806228 | UBS | ||
| Novo Nordisk AS | 13.11.2025 0 Monate | 13.11.2025 | 0 Monate | 303,55 400 | 303,55 | 400 | 31,817433 | BERENBERG | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 303,55 475 | 303,55 | 475 | 56,533202 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 10.11.2025 12 Monate | 10.11.2025 | 12 Monate | 303,55 600 | 303,55 | 600 | 97,726149 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 10.11.2025 12 Monate | 10.11.2025 | 12 Monate | 303,55 | 303,55 | -- | DZ BANK | |||
| Novo Nordisk AS | 10.11.2025 0 Monate | 10.11.2025 | 0 Monate | 303,55 315 | 303,55 | 315 | 3,806228 | UBS | ||
| Novo Nordisk AS | 07.11.2025 0 Monate | 07.11.2025 | 0 Monate | 303,55 315 | 303,55 | 315 | 3,806228 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 303,55 600 | 303,55 | 600 | 97,726149 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 06.11.2025 12 Monate | 06.11.2025 | 12 Monate | 303,55 391 | 303,55 | 391 | 28,851541 | GOLDMAN SACHS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 06.11.2025 0 Monate | 06.11.2025 | 0 Monate | 303,55 540 | 303,55 | 540 | 77,953534 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 06.11.2025 12 Monate | 06.11.2025 | 12 Monate | 303,55 290 | 303,55 | 290 | 4,432361 | JEFFERIES | ||
| Novo Nordisk AS | 06.11.2025 12 Monate | 06.11.2025 | 12 Monate | 303,55 500 | 303,55 | 500 | 64,771791 | JPMORGAN | ||
| Novo Nordisk AS | 05.11.2025 12 Monate | 05.11.2025 | 12 Monate | 303,55 500 | 303,55 | 500 | 64,771791 | JPMORGAN | ||
| Novo Nordisk AS | 05.11.2025 0 Monate | 05.11.2025 | 0 Monate | 303,55 290 | 303,55 | 290 | 4,432361 | JEFFERIES | ||
| Novo Nordisk AS | 05.11.2025 0 Monate | 05.11.2025 | 0 Monate | 303,55 340 | 303,55 | 340 | 12,044818 | UBS | ||
| Novo Nordisk AS | 05.11.2025 0 Monate | 05.11.2025 | 0 Monate | 303,55 540 | 303,55 | 540 | 77,953534 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 05.11.2025 0 Monate | 05.11.2025 | 0 Monate | 303,55 315 | 303,55 | 315 | 3,806228 | UBS | ||
| Novo Nordisk AS | 04.11.2025 0 Monate | 04.11.2025 | 0 Monate | 303,55 540 | 303,55 | 540 | 77,953534 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 303,55 600 | 303,55 | 600 | 97,726149 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 30.10.2025 0 Monate | 30.10.2025 | 0 Monate | 303,55 540 | 303,55 | 540 | 77,953534 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 24.10.2025 0 Monate | 24.10.2025 | 0 Monate | 303,55 290 | 303,55 | 290 | 4,432361 | JEFFERIES |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 22.10.2025 12 Monate | 22.10.2025 | 12 Monate | 303,55 600 | 303,55 | 600 | 97,726149 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 21.10.2025 0 Monate | 21.10.2025 | 0 Monate | 303,55 540 | 303,55 | 540 | 77,953534 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 21.10.2025 0 Monate | 21.10.2025 | 0 Monate | 303,55 340 | 303,55 | 340 | 12,044818 | UBS | ||
| Novo Nordisk AS | 20.10.2025 0 Monate | 20.10.2025 | 0 Monate | 303,55 540 | 303,55 | 540 | 77,953534 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 17.10.2025 12 Monate | 17.10.2025 | 12 Monate | 303,55 500 | 303,55 | 500 | 64,771791 | JPMORGAN | ||
| Novo Nordisk AS | 16.10.2025 0 Monate | 16.10.2025 | 0 Monate | 303,55 540 | 303,55 | 540 | 77,953534 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 10.10.2025 12 Monate | 10.10.2025 | 12 Monate | 303,55 600 | 303,55 | 600 | 97,726149 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 10.10.2025 0 Monate | 10.10.2025 | 0 Monate | 303,55 340 | 303,55 | 340 | 12,044818 | UBS | ||
| Novo Nordisk AS | 09.10.2025 0 Monate | 09.10.2025 | 0 Monate | 303,55 500 | 303,55 | 500 | 64,771791 | JPMORGAN | ||
| Novo Nordisk AS | 06.10.2025 12 Monate | 06.10.2025 | 12 Monate | 303,55 500 | 303,55 | 500 | 64,771791 | JPMORGAN | ||
| Novo Nordisk AS | 06.10.2025 12 Monate | 06.10.2025 | 12 Monate | 303,55 340 | 303,55 | 340 | 12,044818 | UBS | ||
| Novo Nordisk AS | 03.10.2025 0 Monate | 03.10.2025 | 0 Monate | 303,55 340 | 303,55 | 340 | 12,044818 | UBS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 30.09.2025 12 Monate | 30.09.2025 | 12 Monate | 303,55 392 | 303,55 | 392 | 29,181084 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 29.09.2025 12 Monate | 29.09.2025 | 12 Monate | 303,55 500 | 303,55 | 500 | 64,771791 | JPMORGAN | ||
| Novo Nordisk AS | 22.09.2025 0 Monate | 22.09.2025 | 0 Monate | 303,55 340 | 303,55 | 340 | 12,044818 | UBS | ||
| Novo Nordisk AS | 18.09.2025 0 Monate | 18.09.2025 | 0 Monate | 303,55 500 | 303,55 | 500 | 64,771791 | JPMORGAN | ||
| Novo Nordisk AS | 18.09.2025 12 Monate | 18.09.2025 | 12 Monate | 303,55 600 | 303,55 | 600 | 97,726149 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 18.09.2025 12 Monate | 18.09.2025 | 12 Monate | 303,55 600 | 303,55 | 600 | 97,726149 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 17.09.2025 0 Monate | 17.09.2025 | 0 Monate | 303,55 340 | 303,55 | 340 | 12,044818 | UBS | ||
| Novo Nordisk AS | 16.09.2025 0 Monate | 16.09.2025 | 0 Monate | 303,55 425 | 303,55 | 425 | 40,056022 | BERENBERG | ||
| Novo Nordisk AS | 15.09.2025 12 Monate | 15.09.2025 | 12 Monate | 303,55 340 | 303,55 | 340 | 12,044818 | UBS | ||
| Novo Nordisk AS | 15.09.2025 0 Monate | 15.09.2025 | 0 Monate | 303,55 340 | 303,55 | 340 | 12,044818 | UBS | ||
| Novo Nordisk AS | 11.09.2025 12 Monate | 11.09.2025 | 12 Monate | 303,55 600 | 303,55 | 600 | 97,726149 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 10.09.2025 0 Monate | 10.09.2025 | 0 Monate | 303,55 500 | 303,55 | 500 | 64,771791 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 10.09.2025 0 Monate | 10.09.2025 | 0 Monate | 303,55 340 | 303,55 | 340 | 12,044818 | UBS | ||
| Novo Nordisk AS | 08.09.2025 12 Monate | 08.09.2025 | 12 Monate | 303,55 340 | 303,55 | 340 | 12,044818 | UBS | ||
| Novo Nordisk AS | 08.09.2025 12 Monate | 08.09.2025 | 12 Monate | 303,55 540 | 303,55 | 540 | 77,953534 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 05.09.2025 0 Monate | 05.09.2025 | 0 Monate | 303,55 340 | 303,55 | 340 | 12,044818 | UBS | ||
| Novo Nordisk AS | 03.09.2025 0 Monate | 03.09.2025 | 0 Monate | 303,55 500 | 303,55 | 500 | 64,771791 | JPMORGAN | ||
| Novo Nordisk AS | 01.09.2025 0 Monate | 01.09.2025 | 0 Monate | 303,55 340 | 303,55 | 340 | 12,044818 | UBS | ||
| Novo Nordisk AS | 29.08.2025 12 Monate | 29.08.2025 | 12 Monate | 303,55 340 | 303,55 | 340 | 12,044818 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 303,55 600 | 303,55 | 600 | 97,726149 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 26.08.2025 12 Monate | 26.08.2025 | 12 Monate | 303,55 620 | 303,55 | 620 | 104,317021 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 21.08.2025 12 Monate | 21.08.2025 | 12 Monate | 303,55 600 | 303,55 | 600 | 97,726149 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 18.08.2025 0 Monate | 18.08.2025 | 0 Monate | 303,55 340 | 303,55 | 340 | 12,044818 | UBS | ||
| Novo Nordisk AS | 18.08.2025 12 Monate | 18.08.2025 | 12 Monate | 303,55 340 | 303,55 | 340 | 12,044818 | UBS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 11.08.2025 0 Monate | 11.08.2025 | 0 Monate | 303,55 340 | 303,55 | 340 | 12,044818 | UBS | ||
| Novo Nordisk AS | 08.08.2025 12 Monate | 08.08.2025 | 12 Monate | 303,55 | 303,55 | -- | DZ BANK | |||
| Novo Nordisk AS | 08.08.2025 0 Monate | 08.08.2025 | 0 Monate | 303,55 340 | 303,55 | 340 | 12,044818 | UBS | ||
| Novo Nordisk AS | 08.08.2025 0 Monate | 08.08.2025 | 0 Monate | 303,55 620 | 303,55 | 620 | 104,317021 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 07.08.2025 12 Monate | 07.08.2025 | 12 Monate | 303,55 600 | 303,55 | 600 | 97,726149 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 07.08.2025 0 Monate | 07.08.2025 | 0 Monate | 303,55 500 | 303,55 | 500 | 64,771791 | JPMORGAN | ||
| Novo Nordisk AS | 07.08.2025 0 Monate | 07.08.2025 | 0 Monate | 303,55 620 | 303,55 | 620 | 104,317021 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 07.08.2025 12 Monate | 07.08.2025 | 12 Monate | 303,55 392 | 303,55 | 392 | 29,181084 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 06.08.2025 0 Monate | 06.08.2025 | 0 Monate | 303,55 340 | 303,55 | 340 | 12,044818 | UBS | ||
| Novo Nordisk AS | 06.08.2025 0 Monate | 06.08.2025 | 0 Monate | 303,55 500 | 303,55 | 500 | 64,771791 | JPMORGAN | ||
| Novo Nordisk AS | 06.08.2025 0 Monate | 06.08.2025 | 0 Monate | 303,55 415 | 303,55 | 415 | 36,760587 | JEFFERIES | ||
| Novo Nordisk AS | 04.08.2025 12 Monate | 04.08.2025 | 12 Monate | 303,55 400 | 303,55 | 400 | 31,817433 | GOLDMAN SACHS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 04.08.2025 0 Monate | 04.08.2025 | 0 Monate | 303,55 340 | 303,55 | 340 | 12,044818 | UBS | ||
| Novo Nordisk AS | 01.08.2025 12 Monate | 01.08.2025 | 12 Monate | 303,55 620 | 303,55 | 620 | 104,317021 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 30.07.2025 0 Monate | 30.07.2025 | 0 Monate | 303,55 500 | 303,55 | 500 | 64,771791 | JPMORGAN | ||
| Novo Nordisk AS | 30.07.2025 0 Monate | 30.07.2025 | 0 Monate | 303,55 375 | 303,55 | 375 | 23,578843 | BARCLAYS | ||
| Novo Nordisk AS | 29.07.2025 12 Monate | 29.07.2025 | 12 Monate | 303,55 650 | 303,55 | 650 | 114,203328 | JPMORGAN | ||
| Novo Nordisk AS | 29.07.2025 0 Monate | 29.07.2025 | 0 Monate | 303,55 | 303,55 | -- | DZ BANK | |||
| Novo Nordisk AS | 29.07.2025 0 Monate | 29.07.2025 | 0 Monate | 303,55 620 | 303,55 | 620 | 104,317021 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 28.07.2025 12 Monate | 28.07.2025 | 12 Monate | 303,55 620 | 303,55 | 620 | 104,317021 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 303,55 750 | 303,55 | 750 | 147,157687 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 18.07.2025 0 Monate | 18.07.2025 | 0 Monate | 303,55 600 | 303,55 | 600 | 97,726149 | UBS | ||
| Novo Nordisk AS | 15.07.2025 0 Monate | 15.07.2025 | 0 Monate | 303,55 600 | 303,55 | 600 | 97,726149 | UBS | ||
| Novo Nordisk AS | 14.07.2025 0 Monate | 14.07.2025 | 0 Monate | 303,55 610 | 303,55 | 610 | 101,021585 | BERENBERG |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 11.07.2025 0 Monate | 11.07.2025 | 0 Monate | 303,55 700 | 303,55 | 700 | 130,680507 | UBS | ||
| Novo Nordisk AS | 09.07.2025 12 Monate | 09.07.2025 | 12 Monate | 303,55 750 | 303,55 | 750 | 147,157687 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 02.07.2025 0 Monate | 02.07.2025 | 0 Monate | 303,55 700 | 303,55 | 700 | 130,680507 | UBS | ||
| Novo Nordisk AS | 30.06.2025 0 Monate | 30.06.2025 | 0 Monate | 303,55 650 | 303,55 | 650 | 114,203328 | JPMORGAN |
News
Aktuell
Novo Nordisk: mehr als nur Abnehmspritzen – die Chance nach dem Kursrutsch?
Der dänische Pharmakonzern Novo Nordisk dominiert mit den Blockbustern Ozempic und Wegovy (Wirkstoff Semaglutid) den milliardenschweren Markt für Diabetes- und Adipositas-Medikamente. Jüngste Gewinnwarnungen, wachsende Konkurrenz (insbesondere durch Eli Lilly) und regulatorische Unsicherheiten (Nachahmerpräparate, Preisdruck) haben die Aktie stark unter Druck gebracht.
DZ BANK Produktauswahl
Optionsscheine Classic Long
Produktauswahl : Basiswert Novo Nordisk AS
Discount Classic
Produktauswahl : Basiswert Novo Nordisk AS
Endlos Turbos Long
Produktauswahl : Basiswert Novo Nordisk AS
Endlos Turbos Short
Produktauswahl : Basiswert Novo Nordisk AS
Optionsscheine Classic Short
Produktauswahl : Basiswert Novo Nordisk AS
Knock Out Map
- wertpapiere@dzbank.de (069) 7447-7035
-
DZ BANK AG, Platz der Republik,
60265 Frankfurt / M